IRIS
COLECCHIA, MAURIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.747
EU - Europa 3.383
NA - Nord America 1.969
SA - Sud America 1.103
AF - Africa 74
OC - Oceania 4
Totale 10.280
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 2.127
US - Stati Uniti d'America 1.844
SG - Singapore 1.289
CN - Cina 1.197
BR - Brasile 924
HK - Hong Kong 592
VN - Vietnam 358
SE - Svezia 336
IT - Italia 310
FR - Francia 179
DE - Germania 124
GB - Regno Unito 71
AR - Argentina 63
IN - India 61
FI - Finlandia 58
BD - Bangladesh 49
CA - Canada 49
MX - Messico 49
EC - Ecuador 43
AT - Austria 41
IQ - Iraq 33
ID - Indonesia 31
PL - Polonia 26
ES - Italia 25
ZA - Sudafrica 25
TR - Turchia 24
CO - Colombia 20
NL - Olanda 20
JP - Giappone 19
VE - Venezuela 16
PK - Pakistan 14
UZ - Uzbekistan 14
SA - Arabia Saudita 12
TN - Tunisia 11
UA - Ucraina 11
CL - Cile 10
JO - Giordania 10
PY - Paraguay 10
KE - Kenya 9
PE - Perù 9
RO - Romania 9
IE - Irlanda 8
AE - Emirati Arabi Uniti 7
LT - Lituania 7
MA - Marocco 7
AL - Albania 6
CR - Costa Rica 6
PT - Portogallo 6
SN - Senegal 6
EG - Egitto 5
PH - Filippine 5
UY - Uruguay 5
BG - Bulgaria 4
JM - Giamaica 4
KZ - Kazakistan 4
PA - Panama 4
AU - Australia 3
BH - Bahrain 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
GR - Grecia 3
NI - Nicaragua 3
OM - Oman 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BO - Bolivia 2
BY - Bielorussia 2
CY - Cipro 2
ET - Etiopia 2
HU - Ungheria 2
IL - Israele 2
IR - Iran 2
LB - Libano 2
LV - Lettonia 2
NP - Nepal 2
PS - Palestinian Territory 2
AO - Angola 1
AZ - Azerbaigian 1
BE - Belgio 1
BS - Bahamas 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
KR - Corea 1
KW - Kuwait 1
LY - Libia 1
MG - Madagascar 1
MK - Macedonia 1
MY - Malesia 1
NG - Nigeria 1
NR - Nauru 1
PR - Porto Rico 1
QA - Qatar 1
SY - Repubblica araba siriana 1
TG - Togo 1
Totale 10.278
Salva come PNG Salva come JPEG
Città #
Hong Kong 592
Singapore 565
Moscow 506
Shanghai 290
Dallas 286
Ashburn 250
San Jose 201
Hefei 182
Lauterbourg 154
Lawrence 150
Princeton 150
Ho Chi Minh City 149
Beijing 133
New York 109
Milan 103
São Paulo 75
Hanoi 69
Los Angeles 64
Boardman 45
Rio de Janeiro 45
Helsinki 39
Nuremberg 39
Guangzhou 28
Brasília 25
Santa Clara 24
Rome 22
Porto Alegre 21
Belo Horizonte 19
Orem 19
Warsaw 19
Chennai 18
Da Nang 17
Munich 17
Frankfurt am Main 16
Montreal 16
Phoenix 16
Baghdad 15
Curitiba 14
Guayaquil 14
Shenzhen 14
Dhaka 13
Johannesburg 13
Lappeenranta 13
London 13
Manchester 13
Salvador 13
Brooklyn 12
Haiphong 12
Tashkent 12
Tokyo 12
Atlanta 11
Chicago 11
Houston 11
Quito 11
Vienna 11
Amman 10
Ankara 10
Denver 10
Goiânia 10
Mexico City 10
Osasco 10
Poplar 10
Rozzano 10
Council Bluffs 9
Fortaleza 9
Guarulhos 9
Juiz de Fora 9
Mumbai 9
Naples 9
Nova Iguaçu 9
Stockholm 9
Thái Bình 9
Toronto 9
Turin 9
Buenos Aires 8
Buffalo 8
Caxias do Sul 8
Erbil 8
Jakarta 8
Jiaxing 8
Nairobi 8
Querétaro 8
The Dalles 8
Thái Nguyên 8
Tianjin 8
Bogotá 7
Can Tho 7
Cesano Boscone 7
Cluj-Napoca 7
Dublin 7
New Delhi 7
Piracicaba 7
Ribeirão Preto 7
Amsterdam 6
Betim 6
Biên Hòa 6
Boston 6
Campo Grande 6
Charlotte 6
Dakar 6
Totale 5.076
Salva come PNG Salva come JPEG
Nome #
[18F]Fluoro-Deoxy-Glucose positron emission tomography to evaluate lymph node involvement in patients with muscle-invasive bladder cancer receiving neoadjuvant pembrolizumab 205
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02 155
Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer 126
Liquid biopsy of cerebrospinal fluid enabling the detection and therapeutic targeting of the BRAFV600E mutation in a patient with overlapping Erdheim-Chester/Rosai-Dorfman disease 123
A Combination of Cisplatin and 5-Fluorouracil With a Taxane in Patients Who Underwent Lymph Node Dissection for Nodal Metastases From Squamous Cell Carcinoma of the Penis: Treatment Outcome and Survival Analyses in Neoadjuvant and Adjuvant Settings 122
Role of Follicle-stimulating Hormone, Inhibin B, and Anti-Müllerian Hormone in Predicting Sperm Retrieval from Men with Nonobstructive Azoospermia Undergoing Microdissection Testicular Sperm Extraction: A Systematic Review and Meta-analysis 110
Does the administration of preoperative pembrolizumab lead to sustained remission post-cystectomy? First survival outcomes from the PURE-01 study☆ 108
A case report of myoid gonadal stromal tumor treated with testis sparing surgery 106
Anti-Müllerian hormone predicts positive sperm retrieval in men with idiopathic non-obstructive azoospermia-findings from a multi-centric cross-sectional study 106
Total embedding of spermatic cord and hilar soft tissue in orchiectomy for seminoma: does the extensive sampling improve pathologic risk factors? 102
Re: Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-Invasive Bladder Carcinoma with Variant Histologies 102
Cabozantinib Plus Durvalumab in Patients With Advanced Urothelial Carcinoma After Platinum Chemotherapy: Safety and Preliminary Activity of the Open-Label, Single-Arm, Phase 2 ARCADIA Trial 101
Incidence and Clinical Impact of Inflammatory Fluorodeoxyglucose Positron Emission Tomography Uptake After Neoadjuvant Pembrolizumab in Patients with Organ-confined Bladder Cancer Undergoing Radical Cystectomy 100
Pancreatic metastases after surgery for renal cell carcinoma: survival and pathways of progression 99
[The treatment of early-stage germ cell tumors of the testis (GCTT)]. [Il trattamento dei Tumori Germinali del Testicolo (TGT) in fase iniziale.] 99
Cabozantinib as First-line Treatment in Patients With Metastatic Collecting Duct Renal Cell Carcinoma: Results of the BONSAI Trial for the Italian Network for Research in Urologic-Oncology (Meet-URO 2 Study) 98
Leiomyoadenomatoid tumours of the epididymis: A new case report and review of the literature 98
Neoadjuvant pembrolizumab and radical cystectomy in patients with muscle-invasive urothelial bladder cancer: 3-year median follow-up update of PURE-01 trial 95
Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Carcinoma with Variant Histologies 94
Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study 93
An open-label, single-arm, phase 2 study of the Aurora kinase A inhibitor alisertib in patients with advanced urothelial cancer 91
Atypical pleomorphic epithelioid angiomyolipoma localized to the pelvis: a case report and review of the literature 91
A Case of Plasmacytoid Variant of Bladder Cancer With a Single Penile Metastasis and a Complete Response to Carboplatin-Based Chemotherapy and Review of the Literature. 90
Sex cord stromal tumors and tumors of the paratestis: new and old entities in a landscape of rare tumors 81
Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study 79
Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific Societies 79
CD 57 Antigen 78
Definition and Diagnosis of Oligometastatic Bladder Cancer: A Delphi Consensus Study Endorsed by the European Association of Urology, European Society for Radiotherapy and Oncology, and European Society of Medical Oncology Genitourinary Faculty 77
A new mutation in the KIT ATP pocket causes acquired resistance to imatinib in a gastrointestinal stromal tumor patient 77
Carney triad: case report and molecular analysis of gastric tumor 76
Brentuximab Vedotin in CD30-Expressing Germ Cell Tumors After Chemotherapy Failure 75
SOX2 and PRAME in the “reprogramming” of seminoma cells 75
An Open-label Randomized Phase 2 study of Durvalumab Alone or in Combination with Tremelimumab in Patients with Advanced Germ Cell Tumors (APACHE): Results from the First Planned Interim Analysis 73
Penile cancer 73
Benign glomus tumor of the urinary bladder. 73
The 2019 genitourinary pathology society (GUPS) white paper on contemporary grading of prostate cancer 72
Assessment and reporting of pathological findings of penile specimens 70
Carcinoma tiroideo iperfunzionante.Descrizione di un caso. 70
Pathology of testicular and penile neoplasms 70
Immunohistochemistry to Enhance Prognostic Allocation and Guide Decision-Making of Patients With Advanced Urothelial Cancer Receiving First-Line Chemotherapy 69
Multicenter Validation of Histopathologic Tumor Regression Grade After Neoadjuvant Chemotherapy in Muscle-invasive Bladder Carcinoma 68
Large cell calcifying Sertoli cell tumour: molecular and immunohistochemical assessment of a series comprising non-metastasising and metastasising neoplasms 66
Teratoma With Somatic-Type Malignant Components in Germ Cell Tumors of the Testis: A Clinicopathologic Analysis of 40 Cases With Outcome Correlation 66
The Leydig cell tumour Scaled Score (LeSS): a method to distinguish benign from malignant cases, with additional correlation with MDM2 and CDK4 amplification 66
The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System 64
Mediastinal germ cell tumors: A narrative review of their traits and aggressiveness features 63
Dual modulation of MCL-1 and mTOR determines the response to sunitinib 63
Association of Androgen Receptor Expression on Tumor Cells and PD-L1 Expression in Muscle-Invasive and Metastatic Urothelial Carcinoma: Insights for Clinical Research 63
H&E and OCT4/CD34 for the assessment of lympho-vascular invasion in seminoma and embryonal carcinoma 62
Renal tumor biopsy in patients with cT1b-T4-M0 disease susceptible to radical nephrectomy: analysis of safety, accuracy and clinical impact on definitive management 61
Clinical Outcome in Testicular Sex Cord Stromal Tumors: Testis Sparing vs Radical Orchiectomy and Management of Advanced Disease 61
Cystic Clear Cell Renal Cell Carcinoma: A Morphological and Molecular Reappraisal 61
FoxA2 is a reliable marker for the diagnosis of yolk sac tumour postpubertal-type 60
Understanding the somatic-type malignant differentiation in male germ-cell cancer: A work in progress. Response to the article by Spiess et al., Malignant transformation of testicular teratoma: A chemoresistant phenotype. Urol Oncol 2008;26:595-9 60
Salivary duct carcinoma of the parotid gland. Report of a case with cytologic and Immunocytochemical findings on fine needle aspiration biopsy 60
News in the classification of WHO 2022 testicular tumours 60
Potential of the Stromal Matricellular Protein Periostin as a Biomarker to Improve Risk Assessment in Prostate Cancer 59
Evaluation of an institutional series of low-grade oncocytic tumor (LOT) of the kidney and review of the mutational landscape of LOT 59
Different effects of calcitriol and parathyroidectomy on the PTH-calcium curve in dialysis patients with severe hyperparathyroidism 59
Laparoscopic Postchemotherapy Retroperitoneal Lymph-Node Dissection Can Be a Standard Option in Defined Nonseminomatous Germ Cell Tumor Patients 58
Pembrolizumab as neoadjuvant therapy before radical cystectomy in patients with muscle-invasive urothelial bladder carcinoma (PURE-01): An open-label, single-arm, phase II study 58
Detection Rate of Anterior Prostate Cancer in 226 Patients Submitted to Initial and Repeat Transperineal Biopsy 58
Frequent mutation and nuclear localization of β-catenin in sertoli cell tumors of the testis 58
Genomic analysis of spermatocytic tumors demonstrates recurrent molecular alterations in cases with malignant clinical behavior 58
Treatment of Carcinoma In Situ of the Glans Penis With Topical Imiquimod Followed by Carbon Dioxide Laser Excision 56
Persistent CD30 Expression by Embryonal Carcinoma in the Treatment Time Course: Prognostic Significance of a Worthwhile Target for Personalized Treatment 56
Myomelanocytic tumor of the thigh 56
Lack of SYT-SSX fusion transcripts in malignant peripheral nerve sheath tumors on RT-PCR analysis of 34 archival cases 56
Reappraisal of Morphologic Differences Between Renal Medullary Carcinoma, Collecting Duct Carcinoma, and Fumarate Hydratase-deficient Renal Cell Carcinoma 56
Prediction of grade reclassification of prostate cancer patients on active surveillance through the combination of a three-mirna signature and selected clinical variables 56
Integrative transcriptomic analysis reveals distinctive molecular traits and novel subtypes of collecting duct carcinoma 56
Relationship between lymph node ratio and cancer-specific survival in a contemporary series of patients with penile cancer and lymph node metastases 55
Prostatic and urothelial metastasis in the same lymph node: a case report 55
Yolk sac tumor of postpubertal-type does not exhibit immunohistochemical loss of SMARCB1/INI1 and SMARCA4/BRG1…but choriocarcinoma? 54
Treatment and Clinical Outcomes of Patients with Teratoma with Somatic-Type Malignant Transformation: An International Collaboration 54
The Relationship between Characteristics of Inguinal Lymph Nodes and Pelvic Lymph Node Involvement in Penile Squamous Cell Carcinoma: A Single Institution Experience 54
Clinical Outcomes in Clinical N0 Squamous Cell Carcinoma of the Penis According to Nodal Management: Early, Delayed or Selective (following Dynamic Sentinel Node Biopsy) Inguinal Lymph-Node Dissection 54
p15INK4b, p14ARF, and p16INK4a inactivation in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors 53
Reporting Practices and Resource Utilization in the Era of Intraductal Carcinoma of the Prostate: A Survey of Genitourinary Subspecialists 53
Myoid gonadal tumor. Case series, systematic review, and Bayesian analysis 53
The contributions of Juan Rosai to testicular pathology with personal remembrances 53
Exceptional response to olaparib in BRCA2-altered urothelial carcinoma after PD-L1 inhibitor and chemotherapy failure 52
Predicting the pathologic complete response after neoadjuvant pembrolizumab in muscle-invasive bladder cancer 52
Erratum to 'Core Biopsies from Prostate Cancer Patients in Active Surveillance Protocols Harbor PTEN and MYC Alterations'[European Urology Oncology 2 (2019) 277-285 51
TAMs PD-L1(+) in the reprogramming of germ cell tumors of the testis 51
Neoadjuvant sorafenib, gemcitabine, and cisplatin administration preceding cystectomy in patients with muscle-invasive urothelial bladder carcinoma: An open-label, single-arm, single-center, phase 2 study 51
Testicular germ-cell tumours and penile squamous cell carcinoma: Appropriate management makes the difference 51
Immunophenotypic and genotypic analysis of a case of primary peripheral primitive neuroectodermal tumour (pPNET) of the urinary bladder 51
Malaric placentas A quantitative study and clinicopathological correlations 51
How do endoscopic bladder tumor resection techniques affect pathology practice? EAU Section of Uro-Technology (ESUT) and Uropathology (ESUP) survey 50
Myoid gonadal stromal tumours are characterised by recurrent chromosome-level copy number gains: molecular assessment of a multi-institutional series 50
Prostatic metastases from testicular nonseminomatous germ cell cancer: Two case reports and a review of the literature 50
Prognostic Effect of FGFR Mutations or Gene Fusions in Patients with Metastatic Urothelial Carcinoma Receiving First-line Platinum-based Chemotherapy: Results from a Large, Single-institution Cohort 50
Panitumumab Treatment for Advanced Penile Squamous Cell Carcinoma When Surgery and Chemotherapy Have Failed 50
EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study) 50
The Value of Multiparametric Magnetic Resonance Imaging Sequences to Assist in the Decision Making of Muscle-invasive Bladder Cancer 50
pT1 penile squamous cell carcinoma: a clinicopathologic study of 56 cases treated by CO2 laser therapy 50
New Italian guidelines on bladder cancer, based on the World Health Organization 2004 classification 50
First-line therapy with dacomitinib, an orally available pan-HER tyrosine kinase inhibitor, for locally advanced or metastatic penile squamous cell carcinoma: results of an open-label, single-arm, single-centre, phase 2 study 49
Tumors of the testis 49
Totale 7.140
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.514
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.514
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022101 0 5 2 30 6 2 28 6 3 1 5 13
2022/2023700 351 150 37 4 1 89 11 32 10 6 5 4
2023/2024494 13 27 30 154 21 74 44 35 7 22 15 52
2024/20252.608 396 32 70 44 109 193 280 225 476 447 167 169
2025/20266.513 543 501 565 1.062 435 205 573 441 1.919 269 0 0
Totale 10.557